MedPath

Diamyd Medical AB

Diamyd Medical AB logo
🇸🇪Sweden
Ownership
Public
Established
1994-01-01
Employees
25
Market Cap
-
Website
http://www.diamyd.com

Diamyd Medical's DIAGNODE-3 Trial Exceeds Recruitment Target for Early Readout

Diamyd Medical's DIAGNODE-3 trial, a Phase 3 precision medicine study, has recruited 180 patients, surpassing the target for its planned early readout in March 2026.

© Copyright 2025. All Rights Reserved by MedPath